IP Australia has quashed an extension for a patent covering a Bayer oral contraceptive, saying the extension should have been calculated based on a drug that was included on the Australian Register of Therapeutic Goods at an earlier date.
Rideshare giant Uber has lost its bid to prevent a Queensland-based healthcare app from registering its ‘Uberdoc’ trademark despite a “high degree of similarity” to a suite of Uber trade marks.
Astora Women’s Health says group members should accept an open $27 million settlement offer in a class action over its allegedly defective pelvic mesh devices, warning that “financial difficulties” may prevent it from meeting any judgment if the case succeeds at trial.
The Australian Competition and Consumer Commission is investigating claims by suppliers that government bodies have diverted supplies of COVID-19 rapid antigen tests, as the regulator continues its crackdown on reported price gouging amid a test shortage.
A judge has suggested that a class action against the New South Wales government over a mandate requiring healthcare workers to be vaccinated against COVID-19 should be de-classed, saying it was a “straightforward point” because no financial relief was sought.
Israeli drug company Neurim Pharmaceuticals has won an eight month extension to apply for a grace period for its melatonin tablet patent to treat children with autism spectrum disorder after Australian company Generic Partners lost its “inherently implausible” opposition to the patent.
A former head of medical at Sanofi-Aventis has sued the Australian branch of the pharmaceutical giant, claiming he was unfairly dismissed in a “‘sham redundancy” and faced discrimination because of his age and disabilities.
Mylan’s Australia unit is appealing decisions by the tax office to refuse deductions on interest paid under loans taken out by the pharmaceutical giant to help fund the $1.2 billion acquisition of generic drug maker Alphapharm almost 15 years ago.
Bayer has lost its bid to redact the names and contact details of potential group members from discovered documents in a Slater & Gordon-led class action over the drug maker’s Essure contraceptive device.
The maker of the popular Invisalign dental aligners has sued competitor SmileDirectClub for allegedly misleading consumers about the cost and efficacy of its direct-to-consumer teeth alignment kits.